nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—MET—autistic disorder	0.538	1	CbGaD
Crizotinib—ALK—nervous system—autistic disorder	0.000421	0.00222	CbGeAlD
Crizotinib—EPHA5—nervous system—autistic disorder	0.000421	0.00222	CbGeAlD
Crizotinib—MAPK7—brain—autistic disorder	0.000421	0.00222	CbGeAlD
Crizotinib—STK4—cerebellum—autistic disorder	0.00042	0.00221	CbGeAlD
Crizotinib—LYN—nervous system—autistic disorder	0.000419	0.00221	CbGeAlD
Crizotinib—RIPK2—digestive system—autistic disorder	0.000419	0.0022	CbGeAlD
Crizotinib—EPHA8—brain—autistic disorder	0.000416	0.00219	CbGeAlD
Crizotinib—FES—brain—autistic disorder	0.000416	0.00219	CbGeAlD
Crizotinib—STK3—head—autistic disorder	0.000415	0.00219	CbGeAlD
Crizotinib—TIE1—head—autistic disorder	0.000415	0.00219	CbGeAlD
Crizotinib—BMPR1B—nervous system—autistic disorder	0.000413	0.00217	CbGeAlD
Crizotinib—MAP3K19—nervous system—autistic disorder	0.000413	0.00217	CbGeAlD
Crizotinib—YES1—telencephalon—autistic disorder	0.000409	0.00216	CbGeAlD
Crizotinib—EPHA5—central nervous system—autistic disorder	0.000406	0.00214	CbGeAlD
Crizotinib—TYRO3—central nervous system—autistic disorder	0.000406	0.00214	CbGeAlD
Crizotinib—FER—central nervous system—autistic disorder	0.000406	0.00214	CbGeAlD
Crizotinib—ALK—central nervous system—autistic disorder	0.000406	0.00214	CbGeAlD
Crizotinib—TNK2—nervous system—autistic disorder	0.000405	0.00213	CbGeAlD
Crizotinib—IGF1R—nervous system—autistic disorder	0.000405	0.00213	CbGeAlD
Crizotinib—AURKA—head—autistic disorder	0.000405	0.00213	CbGeAlD
Crizotinib—TAOK3—telencephalon—autistic disorder	0.000404	0.00213	CbGeAlD
Crizotinib—LYN—central nervous system—autistic disorder	0.000404	0.00213	CbGeAlD
Crizotinib—TESK1—head—autistic disorder	0.000402	0.00211	CbGeAlD
Crizotinib—BMPR1B—central nervous system—autistic disorder	0.000397	0.00209	CbGeAlD
Crizotinib—MAP3K19—central nervous system—autistic disorder	0.000397	0.00209	CbGeAlD
Crizotinib—EPHA5—cerebellum—autistic disorder	0.000397	0.00209	CbGeAlD
Crizotinib—TYRO3—cerebellum—autistic disorder	0.000397	0.00209	CbGeAlD
Crizotinib—FER—cerebellum—autistic disorder	0.000397	0.00209	CbGeAlD
Crizotinib—SRC—telencephalon—autistic disorder	0.000394	0.00207	CbGeAlD
Crizotinib—TIE1—nervous system—autistic disorder	0.000394	0.00207	CbGeAlD
Crizotinib—MET—brain—autistic disorder	0.000394	0.00207	CbGeAlD
Crizotinib—TNK1—cerebellum—autistic disorder	0.000392	0.00207	CbGeAlD
Crizotinib—MERTK—head—autistic disorder	0.000391	0.00206	CbGeAlD
Crizotinib—TNK2—central nervous system—autistic disorder	0.00039	0.00205	CbGeAlD
Crizotinib—IGF1R—central nervous system—autistic disorder	0.00039	0.00205	CbGeAlD
Crizotinib—PTK2—digestive system—autistic disorder	0.000389	0.00205	CbGeAlD
Crizotinib—TBK1—digestive system—autistic disorder	0.000389	0.00205	CbGeAlD
Crizotinib—BMPR1B—cerebellum—autistic disorder	0.000389	0.00205	CbGeAlD
Crizotinib—CSF1R—eye—autistic disorder	0.000388	0.00204	CbGeAlD
Crizotinib—TYK2—digestive system—autistic disorder	0.000386	0.00203	CbGeAlD
Crizotinib—CSF1R—forebrain—autistic disorder	0.000385	0.00203	CbGeAlD
Crizotinib—AURKA—nervous system—autistic disorder	0.000384	0.00202	CbGeAlD
Crizotinib—LIMK2—head—autistic disorder	0.000382	0.00201	CbGeAlD
Crizotinib—TNK2—cerebellum—autistic disorder	0.000381	0.00201	CbGeAlD
Crizotinib—IGF1R—cerebellum—autistic disorder	0.000381	0.00201	CbGeAlD
Crizotinib—CDK7—brain—autistic disorder	0.000381	0.00201	CbGeAlD
Crizotinib—TESK1—nervous system—autistic disorder	0.000381	0.002	CbGeAlD
Crizotinib—TIE1—central nervous system—autistic disorder	0.000379	0.002	CbGeAlD
Crizotinib—MAP3K12—head—autistic disorder	0.000378	0.00199	CbGeAlD
Crizotinib—ACVR1—head—autistic disorder	0.000378	0.00199	CbGeAlD
Crizotinib—TAOK2—brain—autistic disorder	0.000378	0.00199	CbGeAlD
Crizotinib—MAP4K2—cerebellum—autistic disorder	0.000376	0.00198	CbGeAlD
Crizotinib—RPS6KB1—digestive system—autistic disorder	0.000374	0.00197	CbGeAlD
Crizotinib—FGR—digestive system—autistic disorder	0.000372	0.00196	CbGeAlD
Crizotinib—STK3—cerebellum—autistic disorder	0.000371	0.00195	CbGeAlD
Crizotinib—TIE1—cerebellum—autistic disorder	0.000371	0.00195	CbGeAlD
Crizotinib—MERTK—nervous system—autistic disorder	0.00037	0.00195	CbGeAlD
Crizotinib—STK35—head—autistic disorder	0.00037	0.00195	CbGeAlD
Crizotinib—AURKA—central nervous system—autistic disorder	0.00037	0.00195	CbGeAlD
Crizotinib—TESK1—central nervous system—autistic disorder	0.000366	0.00193	CbGeAlD
Crizotinib—ACVR1B—brain—autistic disorder	0.000364	0.00192	CbGeAlD
Crizotinib—EPHA3—brain—autistic disorder	0.000364	0.00192	CbGeAlD
Crizotinib—LIMK2—nervous system—autistic disorder	0.000362	0.00191	CbGeAlD
Crizotinib—MAP3K12—nervous system—autistic disorder	0.000358	0.00189	CbGeAlD
Crizotinib—ACVR1—nervous system—autistic disorder	0.000358	0.00189	CbGeAlD
Crizotinib—TESK1—cerebellum—autistic disorder	0.000358	0.00189	CbGeAlD
Crizotinib—MERTK—central nervous system—autistic disorder	0.000357	0.00188	CbGeAlD
Crizotinib—BMP2K—head—autistic disorder	0.000356	0.00188	CbGeAlD
Crizotinib—EPHB4—digestive system—autistic disorder	0.000354	0.00186	CbGeAlD
Crizotinib—CSF1R—telencephalon—autistic disorder	0.000354	0.00186	CbGeAlD
Crizotinib—JAK2—digestive system—autistic disorder	0.000351	0.00185	CbGeAlD
Crizotinib—STK35—nervous system—autistic disorder	0.000351	0.00185	CbGeAlD
Crizotinib—LIMK2—central nervous system—autistic disorder	0.000349	0.00184	CbGeAlD
Crizotinib—MERTK—cerebellum—autistic disorder	0.000348	0.00184	CbGeAlD
Crizotinib—JAK3—brain—autistic disorder	0.000347	0.00183	CbGeAlD
Crizotinib—EPHA6—brain—autistic disorder	0.000347	0.00183	CbGeAlD
Crizotinib—EPHA2—digestive system—autistic disorder	0.000347	0.00183	CbGeAlD
Crizotinib—DCLK1—brain—autistic disorder	0.000345	0.00182	CbGeAlD
Crizotinib—MAP3K12—central nervous system—autistic disorder	0.000345	0.00182	CbGeAlD
Crizotinib—ACVR1—central nervous system—autistic disorder	0.000345	0.00182	CbGeAlD
Crizotinib—PTK2B—head—autistic disorder	0.000344	0.00181	CbGeAlD
Crizotinib—PLK4—brain—autistic disorder	0.000343	0.00181	CbGeAlD
Crizotinib—RIPK2—head—autistic disorder	0.000341	0.0018	CbGeAlD
Crizotinib—STK4—brain—autistic disorder	0.000341	0.00179	CbGeAlD
Crizotinib—LIMK2—cerebellum—autistic disorder	0.000341	0.00179	CbGeAlD
Crizotinib—NUAK2—cerebellum—autistic disorder	0.00034	0.00179	CbGeAlD
Crizotinib—STK35—central nervous system—autistic disorder	0.000338	0.00178	CbGeAlD
Crizotinib—BMP2K—nervous system—autistic disorder	0.000338	0.00178	CbGeAlD
Crizotinib—MAP3K12—cerebellum—autistic disorder	0.000337	0.00178	CbGeAlD
Crizotinib—ACVR1—cerebellum—autistic disorder	0.000337	0.00178	CbGeAlD
Crizotinib—FLT3—cerebellum—autistic disorder	0.000337	0.00178	CbGeAlD
Crizotinib—STK35—cerebellum—autistic disorder	0.00033	0.00174	CbGeAlD
Crizotinib—EPHA4—head—autistic disorder	0.00033	0.00174	CbGeAlD
Crizotinib—PTK2B—nervous system—autistic disorder	0.000326	0.00172	CbGeAlD
Crizotinib—BMP2K—central nervous system—autistic disorder	0.000325	0.00171	CbGeAlD
Crizotinib—MAP3K2—head—autistic disorder	0.000324	0.0017	CbGeAlD
Crizotinib—EPHA5—brain—autistic disorder	0.000322	0.0017	CbGeAlD
Crizotinib—FER—brain—autistic disorder	0.000322	0.0017	CbGeAlD
Crizotinib—ALK—brain—autistic disorder	0.000322	0.0017	CbGeAlD
Crizotinib—TYRO3—brain—autistic disorder	0.000322	0.0017	CbGeAlD
Crizotinib—ABL2—cerebellum—autistic disorder	0.000322	0.0017	CbGeAlD
Crizotinib—LYN—brain—autistic disorder	0.00032	0.00169	CbGeAlD
Crizotinib—TNK1—brain—autistic disorder	0.000319	0.00168	CbGeAlD
Crizotinib—BMP2K—cerebellum—autistic disorder	0.000318	0.00167	CbGeAlD
Crizotinib—PTK2—head—autistic disorder	0.000317	0.00167	CbGeAlD
Crizotinib—TBK1—head—autistic disorder	0.000317	0.00167	CbGeAlD
Crizotinib—MAP4K1—brain—autistic disorder	0.000316	0.00166	CbGeAlD
Crizotinib—BMPR1B—brain—autistic disorder	0.000316	0.00166	CbGeAlD
Crizotinib—MAP3K19—brain—autistic disorder	0.000316	0.00166	CbGeAlD
Crizotinib—ABL1—brainstem—autistic disorder	0.000315	0.00166	CbGeAlD
Crizotinib—TYK2—head—autistic disorder	0.000315	0.00166	CbGeAlD
Crizotinib—PTK2B—central nervous system—autistic disorder	0.000314	0.00165	CbGeAlD
Crizotinib—EPHA4—nervous system—autistic disorder	0.000313	0.00165	CbGeAlD
Crizotinib—YES1—digestive system—autistic disorder	0.000313	0.00165	CbGeAlD
Crizotinib—STK10—digestive system—autistic disorder	0.00031	0.00163	CbGeAlD
Crizotinib—TNK2—brain—autistic disorder	0.000309	0.00163	CbGeAlD
Crizotinib—IGF1R—brain—autistic disorder	0.000309	0.00163	CbGeAlD
Crizotinib—TAOK3—digestive system—autistic disorder	0.000309	0.00162	CbGeAlD
Crizotinib—PTK2B—cerebellum—autistic disorder	0.000307	0.00162	CbGeAlD
Crizotinib—MAP3K2—nervous system—autistic disorder	0.000307	0.00162	CbGeAlD
Crizotinib—ABL1—eye—autistic disorder	0.000307	0.00161	CbGeAlD
Crizotinib—MAP4K2—brain—autistic disorder	0.000305	0.00161	CbGeAlD
Crizotinib—RPS6KB1—head—autistic disorder	0.000305	0.00161	CbGeAlD
Crizotinib—RIPK2—cerebellum—autistic disorder	0.000305	0.0016	CbGeAlD
Crizotinib—FGR—head—autistic disorder	0.000303	0.0016	CbGeAlD
Crizotinib—AXL—head—autistic disorder	0.000302	0.00159	CbGeAlD
Crizotinib—EPHA4—central nervous system—autistic disorder	0.000301	0.00159	CbGeAlD
Crizotinib—STK3—brain—autistic disorder	0.000301	0.00159	CbGeAlD
Crizotinib—TIE1—brain—autistic disorder	0.000301	0.00159	CbGeAlD
Crizotinib—SRC—digestive system—autistic disorder	0.000301	0.00158	CbGeAlD
Crizotinib—PTK2—nervous system—autistic disorder	0.0003	0.00158	CbGeAlD
Crizotinib—TBK1—nervous system—autistic disorder	0.0003	0.00158	CbGeAlD
Crizotinib—TYK2—nervous system—autistic disorder	0.000298	0.00157	CbGeAlD
Crizotinib—MAP3K2—central nervous system—autistic disorder	0.000295	0.00156	CbGeAlD
Crizotinib—EPHA4—cerebellum—autistic disorder	0.000294	0.00155	CbGeAlD
Crizotinib—AURKA—brain—autistic disorder	0.000293	0.00155	CbGeAlD
Crizotinib—TESK1—brain—autistic disorder	0.000291	0.00153	CbGeAlD
Crizotinib—TBK1—central nervous system—autistic disorder	0.000289	0.00152	CbGeAlD
Crizotinib—PTK2—central nervous system—autistic disorder	0.000289	0.00152	CbGeAlD
Crizotinib—RPS6KB1—nervous system—autistic disorder	0.000289	0.00152	CbGeAlD
Crizotinib—MAP3K2—cerebellum—autistic disorder	0.000289	0.00152	CbGeAlD
Crizotinib—TYK2—central nervous system—autistic disorder	0.000287	0.00151	CbGeAlD
Crizotinib—FGR—nervous system—autistic disorder	0.000287	0.00151	CbGeAlD
Crizotinib—JAK2—head—autistic disorder	0.000286	0.00151	CbGeAlD
Crizotinib—AXL—nervous system—autistic disorder	0.000286	0.00151	CbGeAlD
Crizotinib—MERTK—brain—autistic disorder	0.000283	0.00149	CbGeAlD
Crizotinib—EPHA2—head—autistic disorder	0.000283	0.00149	CbGeAlD
Crizotinib—TBK1—cerebellum—autistic disorder	0.000283	0.00149	CbGeAlD
Crizotinib—PTK2—cerebellum—autistic disorder	0.000283	0.00149	CbGeAlD
Crizotinib—TYK2—cerebellum—autistic disorder	0.000281	0.00148	CbGeAlD
Crizotinib—ABL1—telencephalon—autistic disorder	0.00028	0.00147	CbGeAlD
Crizotinib—RPS6KB1—central nervous system—autistic disorder	0.000278	0.00147	CbGeAlD
Crizotinib—IRAK1—cerebellum—autistic disorder	0.000277	0.00146	CbGeAlD
Crizotinib—LIMK2—brain—autistic disorder	0.000277	0.00146	CbGeAlD
Crizotinib—FGR—central nervous system—autistic disorder	0.000277	0.00146	CbGeAlD
Crizotinib—MAP3K3—head—autistic disorder	0.000276	0.00145	CbGeAlD
Crizotinib—MAP4K5—head—autistic disorder	0.000276	0.00145	CbGeAlD
Crizotinib—TEK—head—autistic disorder	0.000276	0.00145	CbGeAlD
Crizotinib—NUAK2—brain—autistic disorder	0.000276	0.00145	CbGeAlD
Crizotinib—AXL—central nervous system—autistic disorder	0.000276	0.00145	CbGeAlD
Crizotinib—MAP3K12—brain—autistic disorder	0.000274	0.00144	CbGeAlD
Crizotinib—ACVR1—brain—autistic disorder	0.000274	0.00144	CbGeAlD
Crizotinib—RPS6KB1—cerebellum—autistic disorder	0.000272	0.00143	CbGeAlD
Crizotinib—JAK2—nervous system—autistic disorder	0.000272	0.00143	CbGeAlD
Crizotinib—CSF1R—digestive system—autistic disorder	0.00027	0.00142	CbGeAlD
Crizotinib—AXL—cerebellum—autistic disorder	0.000269	0.00142	CbGeAlD
Crizotinib—STK35—brain—autistic disorder	0.000268	0.00141	CbGeAlD
Crizotinib—EPHA2—nervous system—autistic disorder	0.000268	0.00141	CbGeAlD
Crizotinib—EPHB6—head—autistic disorder	0.000264	0.00139	CbGeAlD
Crizotinib—MAP4K5—nervous system—autistic disorder	0.000262	0.00138	CbGeAlD
Crizotinib—MAP3K3—nervous system—autistic disorder	0.000262	0.00138	CbGeAlD
Crizotinib—TEK—nervous system—autistic disorder	0.000262	0.00138	CbGeAlD
Crizotinib—ABL2—brain—autistic disorder	0.000261	0.00138	CbGeAlD
Crizotinib—JAK2—central nervous system—autistic disorder	0.000261	0.00138	CbGeAlD
Crizotinib—SLK—cerebellum—autistic disorder	0.000259	0.00137	CbGeAlD
Crizotinib—EPHA2—central nervous system—autistic disorder	0.000258	0.00136	CbGeAlD
Crizotinib—BMP2K—brain—autistic disorder	0.000258	0.00136	CbGeAlD
Crizotinib—EPHB4—cerebellum—autistic disorder	0.000257	0.00136	CbGeAlD
Crizotinib—JAK2—cerebellum—autistic disorder	0.000256	0.00135	CbGeAlD
Crizotinib—YES1—head—autistic disorder	0.000255	0.00134	CbGeAlD
Crizotinib—STK10—head—autistic disorder	0.000253	0.00133	CbGeAlD
Crizotinib—MAP4K5—central nervous system—autistic disorder	0.000252	0.00133	CbGeAlD
Crizotinib—TEK—central nervous system—autistic disorder	0.000252	0.00133	CbGeAlD
Crizotinib—MAP3K3—central nervous system—autistic disorder	0.000252	0.00133	CbGeAlD
Crizotinib—TAOK3—head—autistic disorder	0.000252	0.00133	CbGeAlD
Crizotinib—EPHB6—nervous system—autistic disorder	0.00025	0.00132	CbGeAlD
Crizotinib—PTK2B—brain—autistic disorder	0.000249	0.00131	CbGeAlD
Crizotinib—RIPK2—brain—autistic disorder	0.000247	0.0013	CbGeAlD
Crizotinib—MAP4K5—cerebellum—autistic disorder	0.000246	0.0013	CbGeAlD
Crizotinib—TEK—cerebellum—autistic disorder	0.000246	0.0013	CbGeAlD
Crizotinib—MAP3K3—cerebellum—autistic disorder	0.000246	0.0013	CbGeAlD
Crizotinib—SRC—head—autistic disorder	0.000245	0.00129	CbGeAlD
Crizotinib—YES1—nervous system—autistic disorder	0.000242	0.00127	CbGeAlD
Crizotinib—EPHB6—central nervous system—autistic disorder	0.000241	0.00127	CbGeAlD
Crizotinib—STK10—nervous system—autistic disorder	0.00024	0.00126	CbGeAlD
Crizotinib—EPHA4—brain—autistic disorder	0.000239	0.00126	CbGeAlD
Crizotinib—TAOK3—nervous system—autistic disorder	0.000239	0.00126	CbGeAlD
Crizotinib—EPHB6—cerebellum—autistic disorder	0.000235	0.00124	CbGeAlD
Crizotinib—MAP3K2—brain—autistic disorder	0.000235	0.00124	CbGeAlD
Crizotinib—YES1—central nervous system—autistic disorder	0.000233	0.00123	CbGeAlD
Crizotinib—SRC—nervous system—autistic disorder	0.000233	0.00122	CbGeAlD
Crizotinib—STK10—central nervous system—autistic disorder	0.000231	0.00121	CbGeAlD
Crizotinib—TAOK3—central nervous system—autistic disorder	0.00023	0.00121	CbGeAlD
Crizotinib—PTK2—brain—autistic disorder	0.00023	0.00121	CbGeAlD
Crizotinib—TBK1—brain—autistic disorder	0.00023	0.00121	CbGeAlD
Crizotinib—TYK2—brain—autistic disorder	0.000228	0.0012	CbGeAlD
Crizotinib—YES1—cerebellum—autistic disorder	0.000227	0.0012	CbGeAlD
Crizotinib—STK10—cerebellum—autistic disorder	0.000225	0.00119	CbGeAlD
Crizotinib—IRAK1—brain—autistic disorder	0.000225	0.00119	CbGeAlD
Crizotinib—TAOK3—cerebellum—autistic disorder	0.000225	0.00118	CbGeAlD
Crizotinib—SRC—central nervous system—autistic disorder	0.000224	0.00118	CbGeAlD
Crizotinib—RPS6KB1—brain—autistic disorder	0.000221	0.00116	CbGeAlD
Crizotinib—CSF1R—head—autistic disorder	0.00022	0.00116	CbGeAlD
Crizotinib—FGR—brain—autistic disorder	0.00022	0.00116	CbGeAlD
Crizotinib—SRC—cerebellum—autistic disorder	0.000219	0.00115	CbGeAlD
Crizotinib—AXL—brain—autistic disorder	0.000219	0.00115	CbGeAlD
Crizotinib—ABL1—digestive system—autistic disorder	0.000213	0.00112	CbGeAlD
Crizotinib—SLK—brain—autistic disorder	0.000211	0.00111	CbGeAlD
Crizotinib—EPHB4—brain—autistic disorder	0.000209	0.0011	CbGeAlD
Crizotinib—CSF1R—nervous system—autistic disorder	0.000209	0.0011	CbGeAlD
Crizotinib—JAK2—brain—autistic disorder	0.000208	0.00109	CbGeAlD
Crizotinib—EPHA2—brain—autistic disorder	0.000205	0.00108	CbGeAlD
Crizotinib—CSF1R—central nervous system—autistic disorder	0.000201	0.00106	CbGeAlD
Crizotinib—MAP4K5—brain—autistic disorder	0.0002	0.00105	CbGeAlD
Crizotinib—TEK—brain—autistic disorder	0.0002	0.00105	CbGeAlD
Crizotinib—MAP3K3—brain—autistic disorder	0.0002	0.00105	CbGeAlD
Crizotinib—CSF1R—cerebellum—autistic disorder	0.000196	0.00103	CbGeAlD
Crizotinib—EPHB6—brain—autistic disorder	0.000191	0.00101	CbGeAlD
Crizotinib—YES1—brain—autistic disorder	0.000185	0.000973	CbGeAlD
Crizotinib—STK10—brain—autistic disorder	0.000183	0.000964	CbGeAlD
Crizotinib—TAOK3—brain—autistic disorder	0.000182	0.000961	CbGeAlD
Crizotinib—SRC—brain—autistic disorder	0.000178	0.000936	CbGeAlD
Crizotinib—ABL1—head—autistic disorder	0.000174	0.000917	CbGeAlD
Crizotinib—ABL1—nervous system—autistic disorder	0.000165	0.000869	CbGeAlD
Crizotinib—CSF1R—brain—autistic disorder	0.00016	0.00084	CbGeAlD
Crizotinib—ABL1—central nervous system—autistic disorder	0.000159	0.000837	CbGeAlD
Crizotinib—ABL1—cerebellum—autistic disorder	0.000155	0.000818	CbGeAlD
Crizotinib—ABL1—brain—autistic disorder	0.000126	0.000664	CbGeAlD
Crizotinib—CYP3A5—digestive system—autistic disorder	0.000125	0.000658	CbGeAlD
Crizotinib—ABCB1—forebrain—autistic disorder	9.45e-05	0.000498	CbGeAlD
Crizotinib—CYP3A4—digestive system—autistic disorder	9.37e-05	0.000494	CbGeAlD
Crizotinib—ABCB1—telencephalon—autistic disorder	8.69e-05	0.000458	CbGeAlD
Crizotinib—CYP3A4—nervous system—autistic disorder	7.25e-05	0.000382	CbGeAlD
Crizotinib—CYP3A4—central nervous system—autistic disorder	6.98e-05	0.000368	CbGeAlD
Crizotinib—ABCB1—digestive system—autistic disorder	6.64e-05	0.000349	CbGeAlD
Crizotinib—ABCB1—head—autistic disorder	5.41e-05	0.000285	CbGeAlD
Crizotinib—ABCB1—nervous system—autistic disorder	5.13e-05	0.00027	CbGeAlD
Crizotinib—ABCB1—central nervous system—autistic disorder	4.94e-05	0.00026	CbGeAlD
Crizotinib—ABCB1—cerebellum—autistic disorder	4.83e-05	0.000254	CbGeAlD
Crizotinib—ABCB1—brain—autistic disorder	3.92e-05	0.000207	CbGeAlD
Crizotinib—SRC—Signaling Pathways—ADRB2—autistic disorder	2e-06	7.35e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SERPINE1—autistic disorder	2e-06	7.35e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PLA2G4A—autistic disorder	2e-06	7.34e-06	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HRAS—autistic disorder	1.99e-06	7.33e-06	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—autistic disorder	1.99e-06	7.3e-06	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—autistic disorder	1.98e-06	7.27e-06	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—autistic disorder	1.98e-06	7.26e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADSL—autistic disorder	1.97e-06	7.25e-06	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—autistic disorder	1.97e-06	7.24e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL2—autistic disorder	1.97e-06	7.24e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL2—autistic disorder	1.96e-06	7.2e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PTEN—autistic disorder	1.96e-06	7.19e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP19A1—autistic disorder	1.95e-06	7.16e-06	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—HRAS—autistic disorder	1.94e-06	7.14e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MEF2C—autistic disorder	1.94e-06	7.14e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SERPINE1—autistic disorder	1.94e-06	7.14e-06	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—autistic disorder	1.94e-06	7.13e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—XDH—autistic disorder	1.94e-06	7.11e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—autistic disorder	1.94e-06	7.11e-06	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—autistic disorder	1.93e-06	7.09e-06	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—autistic disorder	1.92e-06	7.07e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TSC2—autistic disorder	1.92e-06	7.04e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—MAPK1—autistic disorder	1.92e-06	7.04e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—STX1A—autistic disorder	1.9e-06	6.98e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NPAS2—autistic disorder	1.9e-06	6.98e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PTEN—autistic disorder	1.9e-06	6.98e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MAPK1—autistic disorder	1.89e-06	6.96e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ITGB3—autistic disorder	1.89e-06	6.96e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PRKCB—autistic disorder	1.89e-06	6.95e-06	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—HRAS—autistic disorder	1.89e-06	6.95e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AVP—autistic disorder	1.88e-06	6.91e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DHFR—autistic disorder	1.88e-06	6.9e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—MAPK1—autistic disorder	1.88e-06	6.9e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LEP—autistic disorder	1.88e-06	6.89e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOE—autistic disorder	1.88e-06	6.89e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—APC—autistic disorder	1.87e-06	6.89e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IGF2—autistic disorder	1.87e-06	6.88e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—MAPK1—autistic disorder	1.86e-06	6.83e-06	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—autistic disorder	1.86e-06	6.83e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—EGF—autistic disorder	1.85e-06	6.81e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—PTEN—autistic disorder	1.85e-06	6.81e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PTEN—autistic disorder	1.84e-06	6.78e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL2—autistic disorder	1.84e-06	6.77e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—SERPINE1—autistic disorder	1.84e-06	6.77e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—autistic disorder	1.84e-06	6.74e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TCN2—autistic disorder	1.84e-06	6.74e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—BCL2—autistic disorder	1.83e-06	6.74e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—autistic disorder	1.82e-06	6.67e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—COMT—autistic disorder	1.81e-06	6.66e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APC—autistic disorder	1.81e-06	6.65e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PIK3CG—autistic disorder	1.81e-06	6.65e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTP1—autistic disorder	1.8e-06	6.63e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MAOA—autistic disorder	1.8e-06	6.61e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EGF—autistic disorder	1.79e-06	6.57e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PRKCB—autistic disorder	1.77e-06	6.5e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PLA2G4A—autistic disorder	1.77e-06	6.5e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—autistic disorder	1.77e-06	6.49e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CAT—autistic disorder	1.76e-06	6.45e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADA—autistic disorder	1.75e-06	6.43e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PTEN—autistic disorder	1.73e-06	6.37e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL2—autistic disorder	1.73e-06	6.36e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—POMC—autistic disorder	1.72e-06	6.33e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MEF2C—autistic disorder	1.72e-06	6.32e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—MAPK1—autistic disorder	1.72e-06	6.31e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL2—autistic disorder	1.71e-06	6.27e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—HRAS—autistic disorder	1.71e-06	6.27e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—HRAS—autistic disorder	1.7e-06	6.25e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APC—autistic disorder	1.69e-06	6.22e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PIK3CG—autistic disorder	1.69e-06	6.22e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MAPK1—autistic disorder	1.69e-06	6.2e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TSC2—autistic disorder	1.68e-06	6.17e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ITGB3—autistic disorder	1.68e-06	6.16e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EGF—autistic disorder	1.67e-06	6.15e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—HRAS—autistic disorder	1.67e-06	6.15e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MAPK1—autistic disorder	1.66e-06	6.11e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PLA2G4A—autistic disorder	1.66e-06	6.09e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTM1—autistic disorder	1.66e-06	6.09e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IGF1—autistic disorder	1.66e-06	6.09e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HRAS—autistic disorder	1.64e-06	6.04e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LEP—autistic disorder	1.64e-06	6.04e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOE—autistic disorder	1.64e-06	6.04e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HRAS—autistic disorder	1.63e-06	6.01e-06	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HRAS—autistic disorder	1.63e-06	6e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—autistic disorder	1.63e-06	6e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—SERPINE1—autistic disorder	1.63e-06	5.99e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PTEN—autistic disorder	1.63e-06	5.99e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—autistic disorder	1.63e-06	5.99e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—BCL2—autistic disorder	1.62e-06	5.96e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—HRAS—autistic disorder	1.62e-06	5.96e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL2—autistic disorder	1.62e-06	5.95e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL2—autistic disorder	1.61e-06	5.93e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—POMC—autistic disorder	1.61e-06	5.92e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—autistic disorder	1.61e-06	5.91e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—autistic disorder	1.61e-06	5.91e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PTEN—autistic disorder	1.61e-06	5.9e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTEN—autistic disorder	1.6e-06	5.88e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—RORA—autistic disorder	1.6e-06	5.87e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MAPK1—autistic disorder	1.59e-06	5.85e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GPX1—autistic disorder	1.59e-06	5.83e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—autistic disorder	1.57e-06	5.78e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SERPINE1—autistic disorder	1.57e-06	5.78e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL2—autistic disorder	1.57e-06	5.78e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—autistic disorder	1.56e-06	5.75e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—autistic disorder	1.56e-06	5.75e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—autistic disorder	1.55e-06	5.7e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IGF1—autistic disorder	1.55e-06	5.7e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PRKCB—autistic disorder	1.55e-06	5.69e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MAPK1—autistic disorder	1.54e-06	5.67e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—MAPK1—autistic disorder	1.54e-06	5.67e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HRAS—autistic disorder	1.54e-06	5.65e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PTEN—autistic disorder	1.52e-06	5.6e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HRAS—autistic disorder	1.52e-06	5.59e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—PTEN—autistic disorder	1.52e-06	5.58e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—HRAS—autistic disorder	1.51e-06	5.54e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—MAPK1—autistic disorder	1.51e-06	5.53e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—MAPK1—autistic disorder	1.5e-06	5.51e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOB—autistic disorder	1.5e-06	5.5e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HRAS—autistic disorder	1.49e-06	5.49e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TSC2—autistic disorder	1.49e-06	5.46e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APC—autistic disorder	1.48e-06	5.45e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PIK3CG—autistic disorder	1.48e-06	5.45e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PTEN—autistic disorder	1.48e-06	5.44e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—autistic disorder	1.47e-06	5.41e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SERPINE1—autistic disorder	1.47e-06	5.41e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP19A1—autistic disorder	1.47e-06	5.41e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EGF—autistic disorder	1.47e-06	5.39e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MTHFR—autistic disorder	1.47e-06	5.38e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—autistic disorder	1.45e-06	5.35e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOE—autistic disorder	1.45e-06	5.34e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LEP—autistic disorder	1.45e-06	5.34e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HRAS—autistic disorder	1.45e-06	5.32e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—autistic disorder	1.44e-06	5.3e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—autistic disorder	1.43e-06	5.25e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL2—autistic disorder	1.43e-06	5.25e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—autistic disorder	1.42e-06	5.23e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—POMC—autistic disorder	1.41e-06	5.19e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—MAPK1—autistic disorder	1.41e-06	5.18e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTEN—autistic disorder	1.4e-06	5.15e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TPH2—autistic disorder	1.39e-06	5.11e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—HRAS—autistic disorder	1.38e-06	5.07e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PRKCB—autistic disorder	1.37e-06	5.04e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DPYD—autistic disorder	1.37e-06	5.03e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—COMT—autistic disorder	1.37e-06	5.03e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOE—autistic disorder	1.36e-06	5.01e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTP1—autistic disorder	1.36e-06	5e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MAOA—autistic disorder	1.36e-06	4.99e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IGF1—autistic disorder	1.36e-06	4.99e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HRAS—autistic disorder	1.35e-06	4.98e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—PTEN—autistic disorder	1.34e-06	4.94e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HRAS—autistic disorder	1.34e-06	4.91e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CAT—autistic disorder	1.32e-06	4.87e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MAPK1—autistic disorder	1.32e-06	4.87e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—autistic disorder	1.32e-06	4.85e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APC—autistic disorder	1.31e-06	4.82e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PIK3CG—autistic disorder	1.31e-06	4.82e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MAPK1—autistic disorder	1.31e-06	4.8e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—MAPK1—autistic disorder	1.3e-06	4.78e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EGF—autistic disorder	1.3e-06	4.77e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—autistic disorder	1.3e-06	4.77e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—autistic disorder	1.29e-06	4.74e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—autistic disorder	1.28e-06	4.7e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HRAS—autistic disorder	1.28e-06	4.7e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL2—autistic disorder	1.27e-06	4.68e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.27e-06	4.67e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.25e-06	4.6e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTM1—autistic disorder	1.25e-06	4.6e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—autistic disorder	1.25e-06	4.59e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTEN—autistic disorder	1.24e-06	4.56e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HRAS—autistic disorder	1.24e-06	4.55e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MAPK1—autistic disorder	1.24e-06	4.55e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HRAS—autistic disorder	1.24e-06	4.55e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—MAPK1—autistic disorder	1.23e-06	4.54e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PIK3CG—autistic disorder	1.23e-06	4.52e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—autistic disorder	1.22e-06	4.49e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—HRAS—autistic disorder	1.21e-06	4.44e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HRAS—autistic disorder	1.2e-06	4.42e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MAPK1—autistic disorder	1.2e-06	4.42e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IGF1—autistic disorder	1.2e-06	4.42e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GPX1—autistic disorder	1.2e-06	4.4e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PTEN—autistic disorder	1.2e-06	4.4e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL2—autistic disorder	1.19e-06	4.38e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—autistic disorder	1.19e-06	4.36e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—autistic disorder	1.19e-06	4.36e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—autistic disorder	1.17e-06	4.31e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—autistic disorder	1.16e-06	4.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DHFR—autistic disorder	1.16e-06	4.25e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—autistic disorder	1.15e-06	4.23e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—autistic disorder	1.14e-06	4.19e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—MAPK1—autistic disorder	1.14e-06	4.19e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HRAS—autistic disorder	1.13e-06	4.16e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTEN—autistic disorder	1.12e-06	4.12e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTHFR—autistic disorder	1.11e-06	4.06e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—MAPK1—autistic disorder	1.09e-06	4.02e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—autistic disorder	1.08e-06	3.98e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HRAS—autistic disorder	1.06e-06	3.91e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HRAS—autistic disorder	1.05e-06	3.85e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—HRAS—autistic disorder	1.04e-06	3.84e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2—autistic disorder	1.04e-06	3.83e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOE—autistic disorder	1.03e-06	3.78e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—autistic disorder	1.02e-06	3.74e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—MAPK1—autistic disorder	1.01e-06	3.71e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—autistic disorder	1e-06	3.69e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—autistic disorder	1e-06	3.67e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HRAS—autistic disorder	9.94e-07	3.65e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—HRAS—autistic disorder	9.91e-07	3.64e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTEN—autistic disorder	9.82e-07	3.61e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MAPK1—autistic disorder	9.74e-07	3.58e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HRAS—autistic disorder	9.65e-07	3.55e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—autistic disorder	9.52e-07	3.5e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—autistic disorder	9.49e-07	3.49e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—autistic disorder	9.35e-07	3.43e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PIK3CG—autistic disorder	9.29e-07	3.41e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—autistic disorder	9.24e-07	3.4e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2—autistic disorder	9.24e-07	3.39e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—HRAS—autistic disorder	9.15e-07	3.36e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MAPK1—autistic disorder	9.11e-07	3.35e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	9.06e-07	3.33e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—autistic disorder	8.84e-07	3.25e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—HRAS—autistic disorder	8.77e-07	3.22e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—autistic disorder	8.76e-07	3.22e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTEN—autistic disorder	8.69e-07	3.19e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—COMT—autistic disorder	8.43e-07	3.1e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—autistic disorder	8.4e-07	3.09e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTP1—autistic disorder	8.39e-07	3.08e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOA—autistic disorder	8.37e-07	3.07e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CAT—autistic disorder	8.16e-07	3e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTEN—autistic disorder	8.15e-07	2.99e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—HRAS—autistic disorder	8.1e-07	2.98e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MAPK1—autistic disorder	7.98e-07	2.93e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HRAS—autistic disorder	7.82e-07	2.87e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—autistic disorder	7.75e-07	2.85e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	7.71e-07	2.83e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTM1—autistic disorder	7.71e-07	2.83e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—autistic disorder	7.48e-07	2.75e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GPX1—autistic disorder	7.38e-07	2.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HRAS—autistic disorder	7.32e-07	2.69e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MAPK1—autistic disorder	7.07e-07	2.6e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—autistic disorder	7.05e-07	2.59e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—autistic disorder	7e-07	2.57e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTHFR—autistic disorder	6.81e-07	2.5e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HRAS—autistic disorder	6.41e-07	2.35e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOE—autistic disorder	6.34e-07	2.33e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTEN—autistic disorder	6.15e-07	2.26e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—autistic disorder	6.13e-07	2.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	5.72e-07	2.1e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HRAS—autistic disorder	5.67e-07	2.08e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—autistic disorder	5.45e-07	2e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—autistic disorder	5.43e-07	2e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—autistic disorder	4.34e-07	1.6e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTEN—autistic disorder	3.79e-07	1.39e-06	CbGpPWpGaD
